Sanford Burnham Prebys is one of several institutions contributing to the federally funded project called PREDICTS ...
The new Emerson DeltaV PKM library reportedly cuts months from drug development by providing pre-built specification elements ...
Mike Stenberg, LGM Pharma, outlines how GLP-1s, AI, and 505(b)(2) delivery shifts are driving pharmaceutical innovation.
The revised EU pharmaceutical policy maintains eight-year data protection but reduces market protection to one year, ...
Discover how drugs prevent, cure, and alleviate ailments. Learn about over-the-counter vs. prescription drugs and the ...
Jessica Lin and Zhenqi (Pete) Shi from Genentech describe a novel machine learning approach to predicting retention times for ...
HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) ('HYTN” or the 'Company”), a pharmaceutical-grade cannabis ...
Lubrizol offers an array of pharmaceutical excipients for oral, topical and injectable applications. The company’s portfolio ...
Biphenomycins, natural products derived from bacteria, show excellent antimicrobial activity, but have long remained out of ...
New approach methodologies (NAMs) aim to address the limitations of animal models by assessing drug efficacy and safety in a more ethical, human-relevant way. The term ‘NAMs’ encompasses several ...
Forbes contributors publish independent expert analyses and insights. Gil Press writes about technology, entrepreneurs and innovation. Will AI transform the typical trials and tribulations of drug ...
In the rapidly evolving world of drug development, navigating regulatory requirements, clinical trials, and market demands can be overwhelming for pharmaceutical companies. Many organizations turn to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results